Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Tarsier Pharma
Tarsier Pharma Overview
Tarsier Pharma is a late-clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune inflammatory ocular diseases.
The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases. It is currently being developed as both eye drops and intravitreal injections. TRS has the potential to effectively control a range of autoimmune and inflammatory ocular diseases as potently as steroids but without the negative side effects.
The company's investors include a wholly owned subsidiary company of Sun Pharmaceutical Industries Limited, BioLight Life Sciences Ltd, as well as private investors and family offices.
The company has also received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No. 879598.
Tarsier Pharma announces development of TRS02, a potential immunomodulator, for the treatment of retinal diseases with sustained-release intravitreal formulation
#Expand
Feb 4, 2022
www.calcalistech.com
How one female CEO overcame adversity to find a cure for Uveitis
undefined
Jan 5, 2022
www.prnewswire.com
Tarsier™ Pharma is launching a dedicated website about uveitic glaucoma
#Customers
Dec 1, 2021
www.timesofisrael.com
Israeli pharmaceutical executive wins 2021 EU Prize for Women Innovators
#Investment
Aug 24, 2021
www.prnewswire.com
Tarsier Pharma Raises Capital to Execute Phase-3 Clinical Trial
Tarsier Pharma announces development of TRS02, a potential immunomodulator, for the treatment of retinal diseases with sustained-release intravitreal formulation
#Expand
Feb 4, 2022
www.calcalistech.com
How one female CEO overcame adversity to find a cure for Uveitis
undefined
Jan 5, 2022
www.prnewswire.com
Tarsier™ Pharma is launching a dedicated website about uveitic glaucoma
#Customers
Dec 1, 2021
www.timesofisrael.com
Israeli pharmaceutical executive wins 2021 EU Prize for Women Innovators
#Investment
Aug 24, 2021
www.prnewswire.com
Tarsier Pharma Raises Capital to Execute Phase-3 Clinical Trial
#Investment
View other companies you might be interested in
Tarsier Pharma Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.